Dr Suzanne Saffie-Siebert is the Founder of SiSaf Ltd and inventor of the company’s proprietary Bio-Courier technology, silicon stabilise hybrid lipid nanoparticles (sshLNP).

She has over 25 years of diversified pharmaceutical industry experience with an impressive record of moving pharmaceutical pipelines to commercial success. Suzanne’s broad experience in the Biopharmaceutical industry includes senior leadership positions in areas of research and development, manufacturing, clinical trial, quality control, business development and operations.

Suzanne is one of the pioneers of silicon based drug delivery and is inventor or co-inventor of several drug delivery patents. She earned her PhD from the School of Pharmacy at the University of London and is Visiting Professor at Ulster University. She also obtained a Business in Bioscience Diploma from Oxford Brookes University Business School.